Aptamer‐Modified Homogeneous Catalysts, Heterogenous Nanoparticle Catalysts, and Photocatalysts: Functional “Nucleoapzymes”,“Aptananozymes”, and “ …
Y Ouyang, MP O'Hagan, B Willner… - Advanced …, 2024 - Wiley Online Library
Conjugation of aptamers to homogeneous catalysts (“nucleoapzymes”), heterogeneous
nanoparticle catalysts (“aptananozymes”), and photocatalysts (“photoaptazymes”) yields …
nanoparticle catalysts (“aptananozymes”), and photocatalysts (“photoaptazymes”) yields …
[HTML][HTML] Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases
The delivery of cures for retinal diseases remains problematic. There are four main
challenges: passing through multiple barriers of the eye, the delivery to particular retinal cell …
challenges: passing through multiple barriers of the eye, the delivery to particular retinal cell …
RNA G-quadruplexes and stress: emerging mechanisms and functions
RNA G-quadruplexes (rG4s) are noncanonical secondary structures formed by guanine-rich
sequences that are found in different regions of RNA molecules. These structures have been …
sequences that are found in different regions of RNA molecules. These structures have been …
Nucleic acid-based therapeutics for dermal wound healing
Non-healing wounds have long been the subject of scientific and clinical investigations.
Despite breakthroughs in understanding the biology of delayed wound healing, only limited …
Despite breakthroughs in understanding the biology of delayed wound healing, only limited …
Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer
G Deng, H Zha, H Luo, Y Zhou - Frontiers in Bioengineering and …, 2023 - frontiersin.org
The burden of incidence rate and mortality of cancer is increasing rapidly, and the
development of precise intervention measures for cancer detection and treatment will help …
development of precise intervention measures for cancer detection and treatment will help …
Nanomedicine in cancer therapy
D Fan, Y Cao, M Cao, Y Wang, Y Cao… - Signal Transduction and …, 2023 - nature.com
Cancer remains a highly lethal disease in the world. Currently, either conventional cancer
therapies or modern immunotherapies are non-tumor-targeted therapeutic approaches that …
therapies or modern immunotherapies are non-tumor-targeted therapeutic approaches that …
Aptamer-based probes for cancer diagnostics and treatment
X Hu, D Zhang, Z Zeng, L Huang, X Lin, S Hong - Life, 2022 - mdpi.com
Aptamers are single-stranded DNA or RNA oligomers that have the ability to generate
unique and diverse tertiary structures that bind to cognate molecules with high specificity. In …
unique and diverse tertiary structures that bind to cognate molecules with high specificity. In …
Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer
In the current study, polyethylene glycol (PEG) was linked to polylactide (PLA) through the
synthetic peptide PVGLIG which can be selectively cleaved by the tumor-associated matrix …
synthetic peptide PVGLIG which can be selectively cleaved by the tumor-associated matrix …
Aptamer-Functionalized Ce4+-Ion-Modified C-Dots: Peroxidase Mimicking Aptananozymes for the Oxidation of Dopamine and Cytotoxic Effects toward Cancer Cells
Aptamer-functionalized Ce4+-ion-modified C-dots act as catalytic hybrid systems,
aptananozymes, catalyzing the H2O2 oxidation of dopamine. A series of aptananozymes …
aptananozymes, catalyzing the H2O2 oxidation of dopamine. A series of aptananozymes …
Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21
F Khatami, MM Matin, NM Danesh, AR Bahrami… - Carbohydrate …, 2021 - Elsevier
Herein, a novel targeted delivery system was developed for intracellular co-delivery of
doxorubicin (DOX) as a chemotherapeutic drug, antimiR-21 as an oncogenic antagomiR. In …
doxorubicin (DOX) as a chemotherapeutic drug, antimiR-21 as an oncogenic antagomiR. In …